SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193125-23-096247
Filing Date
2023-04-10
Accepted
2023-04-10 13:37:53
Documents
3
Group Members
COLUMBIA MANAGEMENT INVESTMENT ADVISERS, LLCCOLUMBIA SELIGMAN TECHNOLOGY & INFORMATION FUNDSELIGMAN TECH SPECTRUM (MASTER) FUND

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d476945dsc13ga.htm SC 13G/A 82911
2 EX-99.I d476945dex99i.htm EX-99.I 1069
3 EX-99.II d476945dex99ii.htm EX-99.II 5318
  Complete submission text file 0001193125-23-096247.txt   91404
Mailing Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474
Business Address 1099 AMERIPRISE FINANCIAL CENTER MINNEAPOLIS MN 55474 612-671-8001
AMERIPRISE FINANCIAL INC (Filed by) CIK: 0000820027 (see all company filings)

IRS No.: 133180631 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 6282 Investment Advice

Mailing Address 2155 PARK BOULEVARD PALO ALTO CA 94306
Business Address 2155 PARK BOULEVARD PALO ALTO CA 94306 650-279-9845
Eiger BioPharmaceuticals, Inc. (Subject) CIK: 0001305253 (see all company filings)

IRS No.: 361004130 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87931 | Film No.: 23810546
SIC: 2836 Biological Products, (No Diagnostic Substances)